Advancing knowledge of human development, developmental disabilities, and neurodegenerative diseases.
Waisman investigators Anita Bhattacharyya, PhD, an assistant professor of cell and regenerative biology and Su-Chun Zhang, MD, PhD, professor of neuroscience and neurology at the School of Medicine and Public Health at UW-Madison, were awarded an $11 million Transformative Research grant by the National Institute of Child Health and Human Development (NICHD) of the National …
Waisman Biomafacturing (WB) is at the forefront of the fight against COVID-19 with one vaccine and two therapeutic products in development. “Waisman Biomanufacturing’s mission is to advance novel vaccines and therapeutics into early human clinical trials,” says Carl Ross, MS, WB’s managing director. With its state-of-the-art cleanroom facility, WB provides manufacturing and testing services to …
The COVID-19 pandemic pivoted many daily life activities, such as work and school, to a home base. Healthcare was no exception. In March, the Waisman Center Clinics transitioned all of its services to telehealth appointments using phone and video platforms. The 10 interdisciplinary specialty clinics and the center’s autism treatment program, operated in partnership with …
